← Leaderboards
Gabsang Lee
Johns Hopkins University
$5,579,704
Attributed
$7,261,247
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,261,247 · 5
By mechanism
R01$6,933,747 · 4
R03$327,500 · 1
Top collaborators
- Warren L Grayson8 shared
- Deok-Ho Kim2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Warren L Grayson$2,912,603
- Narutoshi Hibino$4,913,357
- Jung Soo Suk$7,384,031
- Jeannine Coburn$252,156
- Malcolm V Brock$1,716,555
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeIn VivoIn VitroCellsStem CellsGeneticInjuryMouse ModelSiteMyogenesisMuscular AtrophySkeletal MuscleTraumatic InjuryStemGenesMuscleReporterPropertyCell TypeMuscle FibersProliferatingRepairedMuscle RegenerationMyoblasts
Grant awards (22)
High-throughput neurovascular-unit-on-a-chip with OASIS for modeling Parkinson's disease$581,422
R01 · FY2025 · NS
High-throughput neurovascular-unit-on-a-chip with OASIS for modeling Parkinson's disease$590,144
R01 · FY2024 · NS
Regenerating Vascularized and Innervated Skeletal Muscle to Treat VML Defects$411,500
R01 · FY2024 · AR
Regenerating Vascularized and Innervated Skeletal Muscle to Treat VML Defects$51,396
R01 · FY2024 · AR
Regenerating Vascularized and Innervated Skeletal Muscle to Treat VML Defects$424,226
R01 · FY2023 · AR
Regenerating Vascularized and Innervated Skeletal Muscle to Treat VML Defects$77,094
R01 · FY2023 · AR
Regenerating Vascularized and Innervated Skeletal Muscle to Treat VML Defects$6,424
R01 · FY2023 · AR
Regenerating Vascularized and Innervated Skeletal Muscle to Treat VML Defects$419,985
R01 · FY2022 · AR
Regenerating Vascularized and Innervated Skeletal Muscle to Treat VML Defects$428,464
R01 · FY2021 · AR
Interrogating functional and molecular properties of PAX7+ putative skeletal muscle stem/progenitor cells derived from human iPSCs of healthy donors and Duchenne muscular dystrophy patients$348,502
R01 · FY2021 · AR · contact PI
Regenerating Vascularized and Innervated Skeletal Muscle to Treat VML Defects$372,432
R01 · FY2020 · AR
Interrogating functional and molecular properties of PAX7+ putative skeletal muscle stem/progenitor cells derived from human iPSCs of healthy donors and Duchenne muscular dystrophy patients$359,292
R01 · FY2020 · AR · contact PI
Optical control of tau aggregation to model Alzheimer's disease in human neurons$163,750
R03 · FY2020 · AG · contact PI
Interrogating functional and molecular properties of PAX7+ putative skeletal muscle stem/progenitor cells derived from human iPSCs of healthy donors and Duchenne muscular dystrophy patients$359,303
R01 · FY2019 · AR · contact PI
Cell extrinsic factors' roles on direct conversion to human induced neural crest$354,375
R01 · FY2019 · NS · contact PI
Optical control of tau aggregation to model Alzheimer's disease in human neurons$163,750
R03 · FY2019 · AG · contact PI
Interrogating functional and molecular properties of PAX7+ putative skeletal muscle stem/progenitor cells derived from human iPSCs of healthy donors and Duchenne muscular dystrophy patients$359,167
R01 · FY2018 · AR · contact PI
Cell extrinsic factors' roles on direct conversion to human induced neural crest$354,375
R01 · FY2018 · NS · contact PI
Interrogating functional and molecular properties of PAX7+ putative skeletal muscle stem/progenitor cells derived from human iPSCs of healthy donors and Duchenne muscular dystrophy patients$372,521
R01 · FY2017 · AR · contact PI
Cell extrinsic factors' roles on direct conversion to human induced neural crest$354,375
R01 · FY2017 · NS · contact PI
Cell extrinsic factors' roles on direct conversion to human induced neural crest$354,375
R01 · FY2016 · NS · contact PI
Cell extrinsic factors' roles on direct conversion to human induced neural crest$354,375
R01 · FY2015 · NS · contact PI